SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders ...
SAN FRANCISCO and SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and ...
SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)--Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, announced ...
Transcarent has announced its acquisition of Accolade for $7.03 per share in cash, totaling approximately $621 million, creating a combined company with over 1,400 employer and payer clients focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback